Latest News

The recall covers all batches of Urografin 60% manufactured between October 2020 and March 2025.

Awiqli® changes that by offering a single weekly dose, giving patients greater flexibility to fit treatment into their individual lifestyles and preferences.

SAT founder and Chief Medical Officer Dr Peter Zilla, alongside co-developers Dr Roman Gottardi and Dr Martin Czerny, confirmed that the results validate the device’s clinical value.

The study, led by researchers at the Ifakara Health Institute, examines how accessible technology can help patients stay consistent with treatment of TB

TB remains the deadliest infectious disease in the world, and a single untreated case can infect between 15 and 20 people within a year, making early diagnosis and uninterrupted treatment critical tools for containing any outbreak.

The acquisition signals Novartis’s confidence that Exl-111 can outperform this proven therapy by taking an entirely different approach.

The new facility adds to Tajmeel’s growing portfolio of over 30 specialized treatments spanning beauty, regenerative medicine, and surgical transformation.

The gathering brought together stakeholders from multiple sectors to evaluate the country’s progress in developing systems to prevent, detect, and respond to public health emergencies

A core focus of the partnership is building stronger capabilities among eye care professionals, whereby the two organizations will develop and launch specialized training programs designed for doctors and healthcare practitioners working in ophthalmology.